Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10017617
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10017617
Fusion event
HBV-C3 integration
Validated
No
Detection method
TS
Data source
Curated
Sample type
Nontumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2016
PubMed ID
26867494
Virus Sequence
Virus name
HBV
Subtype
C
Reference genome
DQ089769.1
Region type
Polymerase;
Start
960
Integrated sequence
CTACTCCCTTAACTTCATGGGATATGTAATTGGAAGTTGGGGTACCTTACCACAGGAACATATTGTACACAAAATCAAACAATGTTTTCGAAAAATTCCT| |ATAAATAGACCTATTGATTGGAAAGTATGTCAACGAATTGTGGGGCTTCTGGGCTTTGCCGCTCCCTTTACACAATGTGGTTACCCAGCATTAATGCCTT
Host Sequence
Chromosome
chr19
Cytoband
p13.3
Reference genome
GRCh37/hg19
Start
6707967/6707956 (Hg38)
End
6707967/6707956 (Hg38)
Location type
Intronic
Fragile sites / regions
FRA19B
Target gene
C3
miRNAs that regulate target gene
hsa-mir-98-5p
;
hsa-mir-26b-5p
;
hsa-mir-6516-5p
;
hsa-mir-550b-2-5p
;
hsa-mir-455-3p
;
hsa-mir-7847-3p
;
hsa-mir-1227-3p
;
hsa-mir-6880-5p
;
hsa-mir-6799-5p
;
hsa-mir-6851-5p
;
hsa-mir-4252
;
hsa-mir-3689d
;
hsa-mir-6499-3p
;
hsa-mir-6086
;
hsa-mir-377-5p
;
hsa-mir-6134
;
hsa-mir-4537
;
hsa-mir-5186
;
hsa-mir-1247-3p
;
hsa-mir-7151-3p
;
hsa-mir-5095
;
hsa-mir-6889-3p
;
hsa-mir-6504-3p
;
hsa-mir-4438
;
hsa-mir-5001-3p
;
hsa-mir-6720-5p
;
hsa-mir-6512-3p
;
hsa-mir-6729-5p
;
hsa-mir-4649-5p
;
hsa-mir-1273a
;
hsa-mir-661
;
hsa-mir-4486
;
hsa-mir-4522
;
hsa-mir-766-3p
;
hsa-mir-6849-3p
;
hsa-mir-939-3p
;
hsa-mir-4432
;
hsa-mir-589-3p
;
hsa-mir-5698
;
hsa-mir-6722-5p
;
hsa-mir-4638-5p
;
hsa-mir-1307-3p
;
hsa-mir-6741-3p
;
hsa-mir-1306-5p
;
hsa-mir-4284
;
hsa-mir-122-5p
;
hsa-mir-504-3p
;
hsa-mir-3135b
;
hsa-mir-4772-3p
;
hsa-mir-1304-3p
;
hsa-mir-4532
;
hsa-mir-6890-3p
;
hsa-mir-665
;
hsa-mir-887-5p
;
hsa-mir-6780a-5p
;
hsa-mir-6779-5p
;
hsa-mir-3689c
;
hsa-mir-3689b-3p
;
hsa-mir-3689a-3p
;
hsa-mir-30b-3p
;
hsa-mir-1273h-5p
;
hsa-mir-6788-5p
;
hsa-mir-30c-2-3p
;
hsa-mir-30c-1-3p
;
hsa-mir-1273e
;
hsa-mir-6883-5p
;
hsa-mir-6785-5p
;
hsa-mir-4728-5p
;
hsa-mir-149-3p
;
hsa-mir-7106-5p
;
hsa-mir-7160-5p
;
hsa-mir-4722-5p
;
hsa-mir-6884-5p
;
hsa-mir-485-5p
;
hsa-mir-1827
;
hsa-mir-219b-3p
;
hsa-mir-4649-3p
;
hsa-mir-4768-3p
;
hsa-mir-6787-3p
;
hsa-mir-5690
;
hsa-mir-4478
;
hsa-mir-4419b
;
hsa-mir-3929
;
hsa-mir-940
;
hsa-mir-6893-5p
;
hsa-mir-6808-5p
;
hsa-mir-890
;
hsa-mir-302f
;
hsa-mir-216b-5p
;
hsa-mir-216a-5p
;
hsa-mir-7703
;
hsa-mir-4793-3p
;
hsa-mir-1273g-3p
;
hsa-mir-127-5p
;
hsa-mir-1297
;
hsa-mir-25-5p
;
hsa-mir-26a-5p
;
hsa-mir-3192-5p
;
hsa-mir-3199
;
hsa-mir-320e
;
hsa-mir-365a-5p
;
hsa-mir-365b-5p
;
hsa-mir-3928-5p
;
hsa-mir-4459
;
hsa-mir-4465
;
hsa-mir-4635
;
hsa-mir-513c-5p
;
hsa-mir-514b-5p
;
hsa-mir-552-3p
;
hsa-mir-562
;
hsa-mir-5697
;
hsa-mir-6087
;
hsa-mir-658
;
hsa-mir-6806-3p
;
hsa-mir-6819-3p
;
hsa-mir-6877-3p
;
hsa-mir-7843-3p
;
hsa-mir-8052
Nearest miRNA
hsa-mir-1227/Upstream/291445; hsa-let-7e/Downstream/28756;
Nearest TSS
ENST00000633603/Upstream/5084;
ENST00000596543/Downstream/3001;
Nearest CpG islands
None/Target,
chr19-CpG: 112/Upstream/400
,
chr19-CpG: 59/Downstream/29272
Upstream sequence
GAACATCCCGTCCTTCATTGTCCGCCTGGATTCCCAGAAGCACATCGACTTCTCTCTGCGCTCTCCCTACGGGGGTGGCCGCCCGGGCCGCGTGAAGAGG
Downstream sequence
GCAGGGAGGCCAGGCTGACAATTGGGATCCCCCACATATGCACCTGTGTATCTCTTCCCAAATGACCCCACCCTGTCCCACTCTCATCTCCCCCATTCCT
Reference
Chiu, Y. T., et al. Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma. J Hepatol ,2016,64(6): 1256-1264.
Sample Information
×
Sample name
234NT
Sample type
Nontumor
Gender
Female
CpG Island Information
×
Download
Curate